In This Issue: Volume 33, No. 3

April 27, 2016

Natalie Timoshin

Slideshow

Check out what's new in schizophrenia research, personality disorders, patient education, integrative psychiatry, addiction, and more.

Related Videos

Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia

leaders

brain depression

nicotine use

brain schizophrenia

brain

Related Content

Here are highlights from the week in Psychiatric Times.

The Week in Review: May 13-17

Blue Light Blockers: A Behavior Therapy for Mania

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

Postpartum Depression and Psychosis in Psychiatric Times

Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021

schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in Schizophrenia

Here are highlights from the fourth day of this year’s APA Annual Meeting.

The 2024 APA Annual Meeting: Tuesday, May 7

Related Content

Here are highlights from the week in Psychiatric Times.

The Week in Review: May 13-17

Blue Light Blockers: A Behavior Therapy for Mania

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Here’s a look at our recent coverage of these disorders in honor of Mother’s Day 2024.

Postpartum Depression and Psychosis in Psychiatric Times

Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021

schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in Schizophrenia

Here are highlights from the fourth day of this year’s APA Annual Meeting.

The 2024 APA Annual Meeting: Tuesday, May 7

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.